Zhendong Chen

550 total citations
16 papers, 292 citations indexed

About

Zhendong Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Zhendong Chen has authored 16 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 4 papers in Surgery. Recurrent topics in Zhendong Chen's work include Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Zhendong Chen is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Zhendong Chen collaborates with scholars based in China, United States and Australia. Zhendong Chen's co-authors include Yi‐Long Wu, Weineng Feng, Qing Zhou, Jin‐Ji Yang, Wen‐Zhao Zhong, Mingfang Zhao, Yong Song, Z. Wang, Chong‐Rui Xu and Ying Cheng and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Carcinogenesis.

In The Last Decade

Zhendong Chen

13 papers receiving 286 citations

Peers

Countries citing papers authored by Zhendong Chen

Since Specialization

Citations

This map shows the geographic impact of Zhendong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhendong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhendong Chen more than expected).

Fields of papers citing papers by Zhendong Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhendong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhendong Chen. The network helps show where Zhendong Chen may publish in the future.

Co-authorship network of co-authors of Zhendong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhendong Chen. A scholar is included among the top collaborators of Zhendong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhendong Chen. Zhendong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	An open‐label, single‐arm, multicenter, phase II trial of bireociclib as monotherapy for heavily pretreated HR‐positive, HER2‐negative advanced breast cancer patients: BRIGHT‐1 trial 2025 ·Cancer Communications ·Jiayu Wang, Qingyuan Zhang, Tao Sun, Huiping Li, Ying Cheng, Zhongsheng Tong, (unknown), Wei Li, Jingfen Wang, (unknown), Xinhong Wu, Jing Cheng, Zhendong Chen, (unknown), Wang Li, Mingming Liu, (unknown), (unknown), Binghe Xu	1
2	CPRS: a clinical protocol recommendation system based on LLMs 2024 ·International Journal of Medical Informatics ·Jiming Ruan, (unknown), Zhendong Chen, Jihan Huang, Ying Li	1
3	Reactive oxygen species produced by photodynamic therapy enhance docosahexaenoic acid lipid peroxidation and induce the death of breast cancer cells 2024 ·Colloids and Surfaces B Biointerfaces ·(unknown), (unknown), (unknown), Dandan Zhang, (unknown), Zhendong Chen, (unknown), (unknown), Guowei Huang, Shengjun Pan, Yuxin Zheng, Haoyuan Wang, Hao Yang, Lingkun Zhang, Yan‐Qing Guan	2
4	Potential of photodynamic therapy using polycationic photosensitizers in the treatment of lung cancer patients with SARS-CoV-2 infection and bacterial complications: Our recent experience 2024 ·Photodiagnosis and Photodynamic Therapy ·Г. А. Меерович, Е А Коган, И. Д. Романишкин, (unknown), (unknown), (unknown), (unknown), M. G. Strakhovskaya, (unknown), (unknown), (unknown), Yu. M. Romanova, Zhendong Chen, И. В. Решетов	1
5	Circumventing drug resistance in gastric cancer: A spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics 2024 ·Drug Resistance Updates ·(unknown), Jie Yin, Wankun Wang, Yandong Luo, Yiran Chen, Xiongfei Yu, Haiyong Wang, Xiaosun Liu, Zhendong Chen, (unknown), (unknown), (unknown), (unknown), (unknown), Wei Shao, Chao Wu, Jianpeng Sheng, Qing Li, (unknown)	37
6	59P Matching-adjusted indirect treatment comparisons (MAIC) of sotorasib 960mg (soto960) plus panitumumab (pani) vs trifluridine/tipiracil(T/T) plus bevacizumab (bev) in chemorefractory metastatic colorectal cancer (mCRC) 2024 ·Annals of Oncology ·Lisa Salvatore, Marwan Fakih, Yasutoshi Kuboki, David S. Hong, Dominik Paul Modest, Julien Taı̈eb, Timothy Price, Chiara Cremolini, István Májer, Marko Rehn, (unknown), Zhendong Chen, (unknown), Filippo Pietrantonio	1
7	Significant enhancement in vase performance of cut lisianthus ‘Lucetta’: synergism between nano-silver and sucrose 2024 ·The Journal of Horticultural Science and Biotechnology ·Song‐Mei Liu, Zhendong Chen, Hongmei Li, Jiping Liu, (unknown), (unknown), Shenggen He	0
8	540P Phase III study of serplulimab plus chemotherapy as first-line therapy for advanced squamous non-small cell lung cancer: ASTRUM-004 Asian subgroup 2023 ·Annals of Oncology ·Caicun Zhou, Yi Hu, Kejing Ying, Fei Xu, Lin Wu, Xinhua Wang, Hongru Sun, Feng Luo, Jinpeng Shi, Aimin Zang, Yu Pan, Zhendong Chen, Zhenyu Jia, Pei‐Hua Lu, Li Zhang, Ying Cheng, Kang Wang, Qun Wang, Jiayuan Li, (unknown)	1
9	A comprehensive model of genetic-features predicts outcome of personalized adjuvant treatment in resected EGFR-mutant stage II-IIIA NSCLC: Results from a phase III trial (CTONG 1104-ADJUVANT) 2019 ·Annals of Oncology ·Yi‐Long Wu, (unknown), (unknown), Weijian Mao, Lin Wu, Yi Shen, Ying Cheng, (unknown), Linfeng Xu, J. Wang, (unknown), Hua Bao, (unknown), (unknown), Zhendong Chen, Hong‐Hong Yan, Jin Yang, Yongfeng Shao, Qing Zhou, Wen‐Zhao Zhong	0
10	MA15.01 Strong PD-L1 Expression Predicts Poor Response and de Novo Resistance to EGFR TKIs Among Non-Small Cell Lung Cancer Patients with EGFR Mutation 2018 ·Journal of Thoracic Oncology ·Shan Su, Zhong‐Yi Dong, (unknown), Jian Su, Zhendong Chen, Jin‐Ji Yang, Hai‐Yan Tu, Qing Zhou, Wen‐Zhao Zhong, (unknown), Yi‐Long Wu	0
11	Prognostic significance of preoperative albumin-to-globulin ratio in patients with cholangiocarcinoma 2017 ·Current Research in Translational Medicine ·Qu Lin, (unknown), (unknown), (unknown), Xing Li, (unknown), Xiaokun Ma, Dong‐Hao Wu, Zhendong Chen, Min Dong, (unknown), (unknown), Dan‐Yun Ruan, (unknown), (unknown), Xiangyuan Wu, Mingsheng Huang	11
12	2387 Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy 2015 ·European Journal of Cancer ·(unknown), Rujiao Liu, (unknown), Zhendong Chen, Li‐Xin Qiu, Ruixuan Geng, (unknown), (unknown), Jingwen Yin, (unknown), Xiaoyu Zhu	1
13	Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial 2014 ·Annals of Oncology ·Qing Zhou, Ying Cheng, Jin‐Ji Yang, Mingfang Zhao, (unknown), (unknown), Zhendong Chen, Hong‐Hong Yan, Yong Song, Juxiang Chen, Weineng Feng, Chong‐Rui Xu, Z. Wang, (unknown), Wen‐Zhao Zhong, (unknown), Yi‐Long Wu	47
14	Germline mutations of DICER1 in Chinese women with BRCA1/BRCA2-negative familial breast cancer 2014 ·Genetics and Molecular Research ·Wen‐Ming Cao, Yun Gao, Hongjian Yang, (unknown), (unknown), Zhiwen Pan, Zhendong Chen, (unknown), (unknown), Xuan Shao, (unknown)	5
15	Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma 2011 ·Diseases of the Esophagus ·(unknown), (unknown), (unknown), Zhendong Chen, Zhimin Huang, (unknown), Xiaosong Ben, (unknown), (unknown), Donglin Luo, (unknown), Jiaying Lin, (unknown), Yi‐Long Wu	32
16	Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells 2004 ·Carcinogenesis ·Zhendong Chen	152

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact